Geron reported $-28675000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amgen AMGN:US $ 2500M 196M
Bio Techne TECH:US $ 90.45M 28.1M
Cti Biopharma CTIC:US $ -35.1M 0.28M
Cytokinetics CYTK:US $ -80.55M 58.85M
Esperion Therapeutics ESPR:US $ -42989000 12.64M
Exelixis EXEL:US $ 83.24M 33.4M
Genmab GEN:DC 514M 295M
Geron GERN:US $ -28.68M 2.31M
Gilead Sciences GILD:US $ 197M 743M
Macrogenics MGNX:US $ -66638000 8.4M
Novartis NOVN:VX 2.85B 290M
Novavax NVAX:US $ 209.29M 1034.26M
Pain Therapeutics PTIE:US $ -17821000 3.38M
Seattle Genetics SGEN:US $ -133.05M 39.02M
YTE INCY:US $ 116.54M 5.81M